As CEO exits reach a 21-year high, hospitals and health systems look to select their next leader. From board members to financial and clinical leaders, find out
THE RNLI has proved that age is no barrier – after recruiting a number of over-50s from the surfing community to patrol Jersey’s beaches this summer.Following a shortage of experienced lifeguards following the pandemic, the charity ran a recruitm.
Galecto (GLTO) Reports Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BOSTON, Aug. 15, 2023 Galecto, Inc. , a clinical-stage biotechnology company and world leader in galectin biology, focused on the development of novel treatments for fibrosis and cancer, today. -Today at 07:30 am- MarketScreener
In the phase 2b ENLIVEN trial, the investigational drug pegozafermin met both primary endpoints at 24 weeks and led to improvements in fibrosis, paving the way for phase 3 development.